AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 154 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $162,000 | +39.7% | 12,239 | +151.6% | 0.00% | 0.0% |
| Q2 2016 | $116,000 | +16.0% | 4,864 | +13.8% | 0.00% | 0.0% |
| Q1 2016 | $100,000 | +3.1% | 4,275 | +33.6% | 0.00% | 0.0% |
| Q4 2015 | $97,000 | -41.6% | 3,201 | -23.4% | 0.00% | 0.0% |
| Q3 2015 | $166,000 | +137.1% | 4,177 | +312.3% | 0.00% | 0.0% |
| Q2 2015 | $70,000 | -82.6% | 1,013 | -86.3% | 0.00% | -66.7% |
| Q1 2015 | $403,000 | +1579.2% | 7,375 | +1212.3% | 0.00% | – |
| Q4 2014 | $24,000 | +14.3% | 562 | -15.6% | 0.00% | – |
| Q3 2014 | $21,000 | +75.0% | 666 | +10.6% | 0.00% | – |
| Q2 2014 | $12,000 | 0.0% | 602 | 0.0% | 0.00% | – |
| Q1 2014 | $12,000 | -20.0% | 602 | -0.8% | 0.00% | – |
| Q4 2013 | $15,000 | -65.1% | 607 | -69.7% | 0.00% | – |
| Q3 2013 | $43,000 | +79.2% | 2,002 | +81.8% | 0.00% | – |
| Q2 2013 | $24,000 | – | 1,101 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |